Multinational Pilot Study Evaluating the PHENO4U Data Platform in Patients Receiving Total Knee Arthroplasty with Aesculap Implants

What this Trial Is About

Researchers are evaluating the Pheno4U data platform in patients undergoing Total Knee Arthroplasty TKA to collect and analyze implant and patient data. This prospective, multinational pilot study includes adult patients receiving an Aesculap TKA implant, aiming to identify critical risk factors and optimize patient-centered therapies for conditions such as degenerative osteoarthritis and rheumatoid arthritis. Each patient will receive an Aesculap TKA implant as part of their routine clinical care. Data will be gathered through the Pheno4U platform, including patient responses to health questionnaires and measurements of active Range of Motion ROM using the BPMpathway sensor and application. This sensor can also support patients with pre- and postoperative training. Participants will be monitored up to 12 months post-surgery with various assessments, including changes in knee injury and osteoarthritis scores, pain levels, patient satisfaction, and psychological status. The study will track the development of active ROM for up to three months and identify any unknown risks or side effects related to the knee arthroplasty using sensor and app data. The study duration and follow-up are designed to gather comprehensive patient outcome information.

Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty